ICP
TMO icon

Ilex Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History

Ilex Capital Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$77.6M Buy
154,736
+62,722
+68% +$30.1M 1.59% 22
2026
Q1 		$45.2M Buy
+92,014
New +$49.9M 1.11% 35
2025
Q1 		– Sell
-109,534
Closed -$57M – 204
2024
Q4 		$57M Buy
+109,534
New +$60.2M 3.65% 9
2024
Q3 		– Sell
-145,743
Closed -$80.6M – 34
2024
Q2 		$80.6M Buy
145,743
+134,413
+1,186% +$77M 8.26% 3
2024
Q1 		$6.59M Buy
+11,330
New +$6.36M 0.65% 18

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Ilex Capital Partners's TMO Position: Q2 2026 in Review

Ilex Capital Partners increased its Thermo Fisher Scientific (TMO) stake by 68% in Q2 2026, buying an estimated $30.1M and bringing the position to 154,736 shares worth $77.6M. The position accounts for 1.59% of the portfolio, ranked #22.

Ilex Capital Partners first reported a position in TMO in Q1 2024 and has held it in 5 quarters since. The position peaked at $80.6M in Q2 2024. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Ilex Capital Partners held 154,736 shares of Thermo Fisher Scientific worth $77.6M as of Q2 2026.
  • Ilex Capital Partners bought 62,722 Thermo Fisher Scientific shares in Q2 2026, an estimated $30.1M.
  • Thermo Fisher Scientific made up 1.59% of Ilex Capital Partners's portfolio in Q2 2026, its #22 holding.
  • Ilex Capital Partners first reported a position in Thermo Fisher Scientific in Q1 2024 and has held it in 5 quarters since.
  • Ilex Capital Partners's Thermo Fisher Scientific position peaked at $80.6M in Q2 2024.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Ilex Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.